Bezafibrate

Bezafibrate was originally developed as a drug for treatment of hyperlipidemia and used for the prevention of cardiovascular diseases. This fibrate reduces triglyceride and rises HDL-cholesterol^[1]^[2]

^[3] ^[4]

ursodeoxycholic acid and bezafibrate are under study in the treatment of biliar cirrhosis (See Figure in gallery).

Links

Ginseng, green tea or fibrate: valid options for nonalcoholic steatohepatitis prevention?

ATC

Lipid modifying agents

bezafibrate

^[5]

References

References:

↑ How Does Bezafibrate Affect the Plasma HDL Cholesterol Levels?
↑ Determinants of Bezafibrate-induced Improvements in LDL Cholesterol in Dyslipidemic Patients with Diabetes.
↑ Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis
↑ Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis
↑ http://www.whocc.no/atc_ddd_index/?code=C10AB02

Interwiki via Wikidata

[1] How Does Bezafibrate Affect the Plasma HDL Cholesterol Levels?

[2] Determinants of Bezafibrate-induced Improvements in LDL Cholesterol in Dyslipidemic Patients with Diabetes.

[3] Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis

[4] Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis

[5] ttp://www.whocc.no/atc_ddd_index/?code=C10AB02

[1]

[2]

[3]

[4]

[5]

Bezafibrate

Links

ATC

References

Navigation menu

Search